Navigation Links
New Drug Combo for Hepatitis C Shows Promise
Date:1/19/2012

al drugs. Both groups underwent treatment for 24 weeks.

The 10 patients on the four-drug regimen experienced a sustained virologic response with undetectable virus at the end of treatment and again at 12 weeks beyond their treatment, the researchers reported. In the two-drug group, four of the 11 patients also had undetectable levels of the hepatitis C virus in their blood 12 weeks after treatment ended.

All of the patients were infected with genotype 1, the most common type of hepatitis C virus in the United States, and had not responded to previous treatment with interferon and ribavirin, said Lok.

"The four-drug arm was very impressive. These patients had not shown a response before and now we get a 90 to 100 percent rate of sustained response," said Lok.

She said even though only four patients in the two-drug group reached a sustained response, this is the first study to show it can be achieved without interferon or ribavirin.

"Clearly, this is the biggest development in hepatitis C research in a very long time," said Dr. Raymond Chung, director of hepatology at Massachusetts General Hospital in Boston, who wrote an accompanying editorial in the same issue of the journal. "It has enormous implications for our ability to treat many more patients with regimens that are significantly more tolerable."

The most common side effects reported were headache, diarrhea, nausea and fatigue, the study authors said.

Chung called the study "a watershed moment" because it suggests that an interferon-free treatment is possible. "The conventional wisdom for quite some time has been that hepatitis C would likely not be curable without an interferon backbone."

Duke's Dr. Muir added, "The study is also exceptional because it included patients we would describe as the most difficult to treat." Their viral load did not go down very much when they underwent interferon and ribavirin treatment in the past.

The new drugs are not F
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Short-Term Drug Combo May Help Prevent Colon Cancer
2. Bone Marrow Cancer Patients May Benefit From Drug Combo
3. Drug Combo Staves Off Type 2 Diabetes
4. Binge Drinking, Hypertension a Deadly Combo
5. Exercise Combo Best for Type 2 Diabetes
6. New combo lung cancer therapy improves survival over single-line treatment
7. In Women, Diabetes Plus Depression a Deadly Combo
8. Risks May Outweigh Benefits for Blood Pressure Drug Combo
9. Diet-Exercise Combo Seems to Work Best for Obese Seniors
10. Low-Intensity Exercise, Drug Combo Can Help Parkinsons Patients, Studies Show
11. Alcohol-Energy Drink Combo Riskier Than Booze Alone, Study Says
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Drug Combo for Hepatitis C Shows Promise
(Date:11/1/2014)... 01, 2014 Almost half of the country’s ... situation according to a study done by Recorded Future, as ... October 29th. For a little over 9 months, ... how prominent the problem of exposed employee credentials really is ... eye-opening numbers. They determined 221 Fortune 500 companies had employees ...
(Date:11/1/2014)... leading online merchant, TheBeautyPlace.com announced today that a new website ... a website redesign, a sophisticated, clean look, and a new ... an easy online shopping experience. , “We recognized that it ... wayside in e-commerce. With the everlasting presence of mobile technology ... site to our new desktop site will allow us to ...
(Date:11/1/2014)... Tara Haelle HealthDay Reporter ... can both sense adult anger and alter their behavior in ... sponges," said study co-author Andrew Meltzoff, co-director of the University ... "They learn not only from their own direct social experiences ... He said he was most surprised at how emotionally ...
(Date:10/31/2014)... of cell division is central to life. The last ... has fascinated scientists since the dawn of cell biology ... has been notoriously difficult to study this final step, ... in two. , The name given to this process ... and captures the sense of a highly active and ...
(Date:10/31/2014)... 31, 2014 — A team from the Broad ... University of California, Santa Cruz, was awarded one ... Cloud Pilot contracts with the goal of building ... The Cancer Genome Atlas (TCGA) and other datasets ... resources in one cloud environment. This co-location will ...
Breaking Medicine News(10 mins):Health News:Third Party Hacks Can Pose Significant Threat to Businesses, Just Look at the Fortune 500 2Health News:Third Party Hacks Can Pose Significant Threat to Businesses, Just Look at the Fortune 500 3Health News:Third Party Hacks Can Pose Significant Threat to Businesses, Just Look at the Fortune 500 4Health News:Third Party Hacks Can Pose Significant Threat to Businesses, Just Look at the Fortune 500 5Health News:TheBeautyPlace.com to Re-launch Website with New Design and Features 2Health News:Study Shows How Toddlers Adjust to Adult Anger 2Health News:Study Shows How Toddlers Adjust to Adult Anger 3Health News:Cell division, minus the cells 2Health News:Cell division, minus the cells 3Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 2Health News:Broad Institute, Univ. of California team awarded NCI Cancer Genomics Cloud Pilot contract 3
... WASHINGTON, Nov. 2 Over the last few months, ... incorrectly aimed by a few in Congress toward physician ... uncovered the real problem - large, corporate hospitals who ... Last week, the Department of Justice (DOJ) announced that ...
... Stereotactic body radiation therapy (SBRT) stopped the growth of cancer ... among nearly 98 percent of patients with early non-small cell ... surgically removed, according to an updated three-year study presented November ... Society for Radiation Oncology (ASTRO). , The study also shows ...
... Another large community H1N1 influenza clinic has been scheduled ... It will be held at Freedom Hill County Park in ... 3 p.m. Freedom Hill is located at 14900 Metropolitan Parkway. ... community clinics at Freedom Hill, Wednesday through Saturday. A total ...
... NASHVILLE, Tenn., Nov. 2 Brookdale Senior Living Inc. (NYSE: ... results for the third quarter of 2009. , ... strong results this quarter which build on the success of ... is operating effectively in today,s difficult environment as evidenced by ...
... Ill., Nov. 2 Accelify announced today that Indian Prairie ... Medicaid claiming services. Indian Prairie School District serves 28,825 ... State of Illinois. , "We are privileged to have ... its outstanding administrative team," said Alex Brecher, COO of Accelify. ...
... of BPA Were Detected in Some Samples of Green Beans and ... to Cause Harm in Animal Studies; FDA,s Safety Standards for BPA ... Consumer Reports, latest tests of canned foods, including soups, juice, ... 19 name-brand foods tested contain measurable levels of Bisphenol A (BPA). ...
Cached Medicine News:Health News:US Department of Justice Confirms Large Corporate Owned Hospitals Involved in Illegal Contracting Schemes in McAllen Texas, Not Physician Owned Hospitals 2Health News:Stereotactic Radiotherapy Stops Lung Cancer From Growing in Frail Patients 2Health News:Macomb County Announces Another H1N1 Flu Vaccine Clinic Saturday, Nov. 7; Both Types of Vaccine Available for Free 2Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 2Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 3Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 4Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 5Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 6Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 7Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 8Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 9Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 10Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 11Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 12Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 13Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 14Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 15Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 16Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 17Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 18Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 19Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 20Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 21Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 22Health News:Brookdale Announces Third Quarter 2009 Results; CFFO per Share Increases 43% 23Health News:Indian Prairie School District Awards Contract to Accelify 2Health News:Consumer Reports: Tests Find Wide Range of Bisphenol A in Canned Soups, Juice, and More 2Health News:Consumer Reports: Tests Find Wide Range of Bisphenol A in Canned Soups, Juice, and More 3Health News:Consumer Reports: Tests Find Wide Range of Bisphenol A in Canned Soups, Juice, and More 4Health News:Consumer Reports: Tests Find Wide Range of Bisphenol A in Canned Soups, Juice, and More 5
(Date:10/31/2014)... DIEGO, Oct. 31, 2014 Mast Therapeutics, Inc. ... financial results for the quarter ended September 30, 2014. ... Executive Officer, said:  "The third quarter was productive for ... study of MST-188 for sickle cell disease is on ... year. We now have opened 50 study sites in the ...
(Date:10/31/2014)... , October 31, 2014 ... Corporation (NASDAQ: CELG ), Bristol-Myers Squibb Co. ... UNH ), Sanofi SA (NYSE: ... members receive these notes ahead of publication. To reserve ... . , ,-- ,Celgene Corporation Research Reports ,On October ...
(Date:10/31/2014)... -- Encision Inc. (OTCQB:ECIA), a medical device company owning patented ... minimally invasive surgery, today announced financial results for its ... The Company posted quarterly net revenue of $2.279 ... or $(0.04) per share. These results compare to net ... $50 thousand, or $(0.01) per share, in the year-ago ...
Breaking Medicine Technology:Mast Therapeutics Reports Third Quarter 2014 Financial Results 2Mast Therapeutics Reports Third Quarter 2014 Financial Results 3Mast Therapeutics Reports Third Quarter 2014 Financial Results 4Mast Therapeutics Reports Third Quarter 2014 Financial Results 5Mast Therapeutics Reports Third Quarter 2014 Financial Results 6Mast Therapeutics Reports Third Quarter 2014 Financial Results 7Mast Therapeutics Reports Third Quarter 2014 Financial Results 8Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 2Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 3Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 4Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 5Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 6Encision Reports Second Quarter Fiscal Year 2015 Results 2Encision Reports Second Quarter Fiscal Year 2015 Results 3Encision Reports Second Quarter Fiscal Year 2015 Results 4Encision Reports Second Quarter Fiscal Year 2015 Results 5
... DURHAM, N.C.--(BUSINESS WIRE)--Jul 3, 2007 - Inspire,Pharmaceuticals, Inc. ... and CEO, will present at the C.E.,Unterberg, Towbin ... at 11:00 am ET in New York City., ... on Inspire's,web site at www.inspirepharm.com. An archived version ...
... 28, 2007 /PRNewswire-FirstCall/ -- Auxilium,Pharmaceuticals, Inc. today announced ... and Mr. Jim Fickenscher, Chief,Financial Officer, will participate ... be held July 10 through July 12,2007 at ... Mr. Anido is,scheduled to present an overview of ...
Cached Medicine Technology:Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging,Growth Opportunities Conference 2Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging,Growth Opportunities Conference 3
Suture scissor...
Threaded cannula for use with Suretac® II, sterile packs, box of 10....
The Small Oval Cannula System is designed to be the smallest oval cannula system currently available, and is utilized with the Caspari Suture Punch System. Disposable seals are available with this sy...
... is for arthroscopic and open soft tissue repair ... procedural steps. It may be used with ... in conjunction with,anchors or screws (including suture pre-assembled ... tip permits the placement of a variety of ...
Medicine Products: